Related Experiment Video

Updated: Aug 23, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia

Alain Combes1, Charles-Edouard Luyt, Jean-Yves Fagon

  • 1Service de Réanimation Médicale, Hôpital Pitié-Salpêtrière, 75651 Paris Cedex 13, France. alain.combes@psl.ap-hop-paris.fr

American Journal of Respiratory and Critical Care Medicine
|July 10, 2004
PubMed

Insights

Methicillin resistance in Staphylococcus aureus ventilator-associated pneumonia (VAP) did not significantly impact patient mortality. Appropriate antibiotics were administered, and outcomes were similar between susceptible and resistant strains.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Severe Staphylococcus aureus infections, particularly ventilator-associated pneumonia (VAP), pose significant clinical challenges.
  • The role of methicillin resistance in Staphylococcus aureus (MRSA) on patient outcomes remains a subject of debate.

Purpose of the Study:

  • To investigate the impact of methicillin resistance on morbidity and mortality in patients with severe Staphylococcus aureus VAP.
  • To determine if MRSA VAP is associated with increased mortality compared to methicillin-susceptible Staphylococcus aureus (MSSA) VAP when appropriate initial antibiotic therapy is provided.

Main Methods:

  • Retrospective cohort study analyzing 97 patients with MSSA VAP and 74 patients with MRSA VAP.
  • Multivariate logistic regression analysis was used to identify factors associated with 28-day mortality.
  • Appropriate initial empiric antibiotic therapy was confirmed for all included patients.

Main Results:

  • Patients with MRSA VAP were older, had higher disease severity scores, and longer durations of mechanical ventilation prior to VAP onset.
  • Age and the Day 1 Organ Dysfunction or Infection (ODIN) score were significant predictors of 28-day mortality.
  • Methicillin resistance was not found to be a significant independent predictor of 28-day mortality (OR = 1.72, p = 0.22).
  • Rates of infection relapse or superinfection did not differ significantly between MRSA and MSSA groups.

Conclusions:

  • After adjusting for clinical and physiological differences, methicillin resistance did not significantly influence 28-day mortality in patients with Staphylococcus aureus VAP receiving appropriate antibiotics.
  • These findings suggest that appropriate antibiotic selection is crucial for managing both MRSA and MSSA VAP.
  • Further research may be warranted to explore other potential factors influencing outcomes in MRSA VAP.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...